Term
|
Definition
| drugs that prevent clot formation |
|
|
Term
|
Definition
| drugs that prevent platelet aggregation |
|
|
Term
|
Definition
| drugs that eliminate clots |
|
|
Term
|
Definition
| PO drug that interferes with specific vit K dependant clotting factors |
|
|
Term
|
Definition
| IV drug that inhibits formation of fibrin clots (turns off clotting pathways) |
|
|
Term
|
Definition
| SubQ drug that produces a very stable response for anticoagulation with less chance of bleeding than heparin |
|
|
Term
|
Definition
antidote for heparin and LMWH
- given IV over 10 minutes |
|
|
Term
|
Definition
| when giving protamine sulfate (Heparin and LMWH antidote) the nurse should watch for |
|
|
Term
| vitamin K - whole blood - platelets |
|
Definition
| antidote for warfarin (coumadin) |
|
|
Term
|
Definition
| for Heparin, clotting time should be _____ faster than control time |
|
|
Term
| APTT (activated partial thromboplastin time) |
|
Definition
| lab test used to check clotting factors in IV or SC Heparin |
|
|
Term
|
Definition
| for LMWH (lovonox), clotting time should be _____ faster than control time |
|
|
Term
|
Definition
| for Warfarin (coumadin), clotting time should be _____ faster than control time |
|
|
Term
|
Definition
| lab test used to check clotting factors in Lovonox |
|
|
Term
|
Definition
| lab tests used to check clotting factors in warfarin (coumadin) |
|
|
Term
|
Definition
| preferred antiplatelet - prolongs bleeding time |
|
|
Term
| eptifibatide (intergrillin) |
|
Definition
| antiplatelet used to treat unstable angina acute coronary syndrome |
|
|
Term
|
Definition
| another name for thrombolytics |
|
|
Term
|
Definition
| thrombolytics convert plasminogen to ________ which prevents tissue necrosis |
|
|
Term
|
Definition
| enzyme that breaks up clots when thrombolytics are used |
|
|
Term
| alteplase recombinant (Activase) |
|
Definition
|
|
Term
|
Definition
| activase(thrombolytic) must be given within ____ of an MI and ____ of thrombotic stroke |
|
|
Term
|
Definition
| Heparin doses are adjusted _____, based on APTT |
|
|
Term
|
Definition
| when beginning treatment, a loading dose of _______ may be given, followed by warfarin |
|
|
Term
|
Definition
| postop anticoagulant therapy may last up to ________ |
|
|
Term
| extra pressure for 30 minutes - bandages |
|
Definition
| inverventions for bleeding at IV site with anticoagulants |
|
|
Term
|
Definition
| with anticoagulants, pt should limit food high in ___________ |
|
|
Term
|
Definition
| antiplatelets should be stopped ______ prior to surgery |
|
|
Term
|
Definition
| preffered type of drugs for hypertension |
|
|
Term
|
Definition
| drugs that supress the renin-angiotensin system. Stop Angiotensin I to Angiotensin II so Na and water are excreted = decrease BP |
|
|
Term
| ARBs (angiotensin II receptor blockers) |
|
Definition
| drugs that stop the binding of angiotensin II at receptor sites |
|
|
Term
|
Definition
IV drug given for hypertensive crisis
- no time to wait for PO to work |
|
|
Term
| ulcers, GI upset, anorexia, constipation |
|
Definition
| GI adverse effects of ACE inhibitors |
|
|
Term
| Rash, pertusis, cough, dry mouth, tahycardia, hypotension, neutropenia |
|
Definition
| non-GI adverse effects of ACE inhibitors |
|
|
Term
| edema, H/A, flushing, nausea, constipation, nervousness |
|
Definition
| non-cardiac adverse effects of Ca channel blockers |
|
|
Term
| bradycardia, hypotension, arrhythmias |
|
Definition
| cardiac adverse effects of calcium channel blockers |
|
|
Term
| hypotension, upper respiratory symptoms, cough |
|
Definition
| adverse effects of ARBs (angiotensin receptor blockers) |
|
|
Term
| verapamil (Ca channel blocker) |
|
Definition
| antihypertensive that should be given with food |
|
|
Term
|
Definition
| these antihypertensive drugs can not be taken by someone who is pregnant or may become pregnant |
|
|
